Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-005215-16Phase 4Completed
Phase 4, randomised trial of propofol (2 arms), sponsored by CHU Brugmann. Primary endpoint: Time to fit for discharge. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-005215-16.